BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

VAXIN PHARMACEUTICALS INC

via BALCH & BINGHAM, LLP

2nd Quarter (Apr 1 - June 30) · 2009Posted Jul 10, 2009Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: VAXIN PHARMACEUTICALS INC
Location: Alabama · United States of America

Registrant

Firm: BALCH & BINGHAM, LLP
Description: law firm
Location: Birmingham, Alabama, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Funding for Immunocontraceptive vaccines through Department of Interior, Agriculture or Transportation Appropriations bills; in ovo vaccination by recombinant adenovirus vectors through Department of Agriculture or Homeland Security Appropriations bills; non-invasive vectored vaccine research through Department of Defense Authorization or Defense Appropriations bills.
Lobbyistsmr MICHAEL J DAVIS ii · mr WILLIAM F STIERS
Covered position (mr MICHAEL J DAVIS ii): Field Representative - Sen. Jeff Sessions
Covered position (mr WILLIAM F STIERS): Leg. Dir. - Reps. Wm. Dickinson and Terry Everett
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

VAXIN PHARMACEUTICALS INC — Lobbying — Receipts Report